Navigation Links
Abstinence in Medical Technology

Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results

... vigabatrin met its primary efficacy endpoint of abstinence during the last weeks of treatment for ... to those receiving placebo. Achievement of abstinence for an extended period during treatment is the ... cocaine addicted patients to potentially achieve abstinence for much longer time periods. The data confirm ...

Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months

... Identified for Smoking Cessation and Long-Term abstinence A statistically significant number of patients ... Antibody Levels Drive Long-Term Smoking abstinence * The rate of smoking cessation and ability to achieve long-term abstinence in treated patients was correlated with level of ...

Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months

... statistically significant and continuous abstinence rates by dose as well as by antibody response. ... endpoint of eight weeks of continuous abstinence between weeks 19-26. NicVAX Nine-Month Data Key ... continued to show statistically significant abstinence at nine months: -- 9-Month ...

Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis

... abstinence is still the best policy ROCHESTER, Minn., Dec. 1 ... other anti-inflammatory proteins for study purposes." Complete abstinence from alcohol is the single most important treatment for alcoholic ...

Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction

... As a result, drug therapies are desperately needed which can improve abstinence achievement rates of behavioral therapy administered by addiction ... controlled trial, in which vigabatrin met its primary efficacy endpoint of abstinence during the last weeks of treatment for cocaine addiction. Additional ...

'Brain Signature' for Cigarette Cravings Identified

... professor of Neurology at Penn, this study is the first to show how abstinence from nicotine produces brain activation patterns that relate to urges to ... CBF across two scanning sessions which varied by length of periods of abstinence from smoking. Fifteen regular smokers were included in the study. Each ...

Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results

... continues to demonstrate efficacy in support of long-term smoking abstinence - the most effective NicVAX dose regimen was 400 micrograms delivered ... which met its primary endpoint of eight weeks of continuous smoking abstinence between weeks 19-26 -- Participated in the Phacilitate Vaccine Forum ...

Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study

... male partners. A safe and effective vaginal microbicide could offer a readily available approach for many women who cannot simply rely on condoms or abstinence as methods for protecting themselves from HIV. Even a partially effective microbicide could have a profound impact on the dynamics of HIV ...

Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction

... no adjunctive drug products approved for the treatment of this population. As a result, drug therapies are desperately needed which can improve abstinence achievement rates of behavioral therapy currently obtained by addiction treatment specialists, and reduce recidivism." About Methamphetamine ...

CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

... use during therapy and for 6 weeks after stopping CellCept. Two reliable forms of contraception must be used simultaneously unless abstinence is the chosen method. Patients should be aware that CellCept reduces blood levels of the hormones in the oral contraceptive pill and could ...

Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

... use during therapy and for 6 weeks after stopping CellCept. Two reliable forms of contraception must be used simultaneously unless abstinence is the chosen method. Patients should be aware that CellCept reduces blood levels of the hormones in the oral contraceptive pill and could ...

Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results

... moderate to severe Alzheimer's disease; Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation; and Bystolic(R) (nebivolol), a beta-adrenergic receptor ...

Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD

... moderate to severe Alzheimer's disease; Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation; and Bystolic(R) (nebivolol), a beta-adrenergic receptor ...

Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies

... moderate to severe Alzheimer's disease; Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation; and Bystolic(TM) (nebivolol), a beta-adrenergic receptor ...

Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression

... to severe Alzheimer's disease; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. In addition to our growing product line, Forest also ...

YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country

... support YouthAIDS programs in nations throughout the world, like voluntary counseling and testing services in Rwanda, food provision in Botswana and abstinence awareness campaigns in Zambia. Many Kick Me! Campaign school visits and special events will occur across the country during the month of November ...

Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show

... to severe Alzheimer's disease; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. In addition to our growing product line, Forest also ...

Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)

... to severe Alzheimer's disease; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. In addition to our growing product line, Forest also ...

Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension

... for the treatment of hypertension; and Campral(R) * (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. * Benicar is a registered trademark of Daiichi Sankyo, ...

Early Results of the CellCept Spare the Nephron Study Examine Kidney Function

... during therapy and for six weeks following discontinuation of therapy. Two reliable forms of contraception must be used simultaneously unless abstinence is the chosen method. If pregnancy occurs during treatment, the physician and patient should discuss the desirability of continuing the pregnancy ...

Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril

... product is not indicated for initial therapy; Campral(R)** (acamprosate calcium), a glutamate receptor modulator, indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation in combination with psychosocial support; and Combunox(TM) ...

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome

... for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. * Benicar is a registered trademark of Daiichi ...

Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2) Do Not Demonstrate Difference Between Desmoteplase and Placebo

... for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. *Benicar is a registered trademark of Daiichi Sankyo, ...

Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis

... during therapy and for six weeks following discontinuation of therapy. Two reliable forms of contraception must be used simultaneously unless abstinence is the chosen method. If pregnancy occurs during treatment, the physician and patient should discuss the desirability of continuing the pregnancy ...
Other Contents
(Date:7/14/2014)... depleting our arsenal against deadly diseases and infections, ... research shows promise to speed up the drug ... ACS Chemical Biology , University of Illinois ... novel, medically relevant products produced by bacteria. , ... to find a novel product, said principal investigator ...
(Date:7/14/2014)... control insect body size? What influence does genetics have on ... Current Opinion in Insect Science launched today ... Current Opinion in Insect Science is the latest title ... journal that aims to provide specialists with a unique platform ... in the field of insect science. First articles published are ...
(Date:7/14/2014)... local environment manage much better in the struggle for ... , A world without bees would be a whole ... 600 million to 1 billion Danish kroner are earned ... honey and pollinating a wide range of crops from ... over the world are under pressure from pesticides, mites, ...
Breaking Biology News(10 mins):Innovative technique may transform the hunt for new antibiotics and cancer therapies 2Innovative technique may transform the hunt for new antibiotics and cancer therapies 3Best for bees to be stay-at-homes 2
(Date:7/14/2014)... A new theory of how cancer works could lead ... , The theory suggests that cancer forms when recently ... to using older, inappropriate genetic pathways. , Astrobiologists ... Professor Paul Davies from Arizona State University teamed up ... Western Ontario to develop the new model. , ...
(Date:7/14/2014)... 14, 2014 The governments in many ... the Global Mobile Health Solutions market. For instance, in ... IT for Economic and Clinical Health Act under the ... Analysts forecast the Global Mobile Health Solutions market ... over the period 2013-2018. According to the report, one ...
(Date:7/14/2014)... The report “Intelligent Building Automation Technologies Market by ... Management], IT Technologies & Industry Verticals - Global ... defines and segments the IBAS market into various ... revenues. The report also identifies the factors driving ... along with the technology roadmap and adoption trends. ...
(Date:7/14/2014)... fitness may buffer some of the adverse health effects ... by researchers from the American Cancer Society, The Cooper ... in the journal Mayo Clinic Proceeding s, and ... and blood markers associated with cardiovascular disease is markedly ... behavior has been linked to an increase risk of ...
(Date:7/14/2014)... 2014 This report provides quantitative ... Americas. The analysis includes market size data by ... key company share data by revenue in 2013 ... Mexico. It uses data and information sourced from ... analysis. , Scope,     Information on ...
Breaking Medicine News(10 mins):Health News:New theory turns cancer on its head 2Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 2Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 3Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 4Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Physical fitness associated with less pronounced effect of sedentary behavior 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4
Other TagsOther Tags